Main Session
Sep
29
PL 01 - Plenary
1 - Primary Results from NRG-GU005: A Phase III Trial of SBRT vs. Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Presenter(s)
Rodney Ellis, MD - University South Florida and Tampa General Hospital Cancer Institute, Tampa, FL